Fig. 1From: Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician surveyEstimated proportion of adults with B-precursor ALL tested for MRD amongst clinicians who test for MRD. Footnote: ALL, acute lymphoblastic leukemia; CR1, first complete remission; CR2+, second complete remission or later; MRD, minimal residual diseaseBack to article page